Skip to content

CPC in Adult Refractory Glaucoma

Evaluation of Diode Laser Cyclophotocoagulation in Adult Refractory Glaucoma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04921098
Enrollment
25
Registered
2021-06-10
Start date
2021-07-01
Completion date
2022-04-30
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Glaucoma

Brief summary

The purpose of this study is to assess the relative effectiveness and safety of diode laser cyclophotocoagulation procedure to reduce IOP and relieve pain in adult patients with refractory glaucoma.

Detailed description

A hospital -based, prospective interventional non comparative case series study.This study will be conducted on patients with refractory glaucoma whose ages are 18 years and older.They will be subjected to Transscleral Diode Laser Cyclophotocoagulation. Postoperative evaluation will be scheduled for the first day postoperative, then 1 week later and then at 1st, 3rd, month postoperative.

Interventions

PROCEDUREDiode Laser Cyclophotocoagulation

A handpiece (G probe) is used to deliver the diode laser energy with a wavelength of 810 nm.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Inclusion Criteria: 1. Patients with refractory glaucoma aging 18 years and older. 2. Both sexes are included. 3. Patients Capable of giving informed consent. 4. Pseudophkic glaucoma. 5. Aphakic glaucoma. 6. Silicon oil induced glaucoma. 7. Neovascular glaucoma. 8. Inflammatory glaucoma.

Exclusion criteria

1. Patients \<18 years of age. 2. Patients controlled on regular antiglaucomatous therapy. 3. Patients who cannot do regular follow up visits. 4. Diffuse scleral staphyloma at the site of CPC.

Design outcomes

Primary

MeasureTime frameDescription
change in intraocular pressureFirst day postoperative and 1 weekIOP measuring using Goldmann applanation tonometer.

Countries

Egypt

Contacts

Primary ContactMina A Besada, Resident
mena011205@med.sohag.edu.eg01280899267
Backup ContactIsmail M Abdellatif, Professor
01223629352

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026